Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas - Related Studies

Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas

This study is currently recruiting participants.

Study NCT00528684. Last updated on July 30, 2008. Information provided by Oncolytics Biotech

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Malignant Glioma

2	Additional conditions recognized in this trial
		Glioma

3	More general conditions related to this trial
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Glandular and Epithelial
		Neoplasms, Nerve Tissue
		Neoplasms, Neuroepithelial
		Neuroectodermal Tumors

4	Interventions listed in this trial
		REOLYSIN

5	Sponsors listed in this trial
		Oncolytics Biotech